| |
| |
|
| Insider
Information: |
Desouza Errol B |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
332,188 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,609,255 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
332,188 |
|
|
| Total
Value |
$12,609,255 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idexx Laboratories Inc |
IDXX |
Director |
2009-04-30 |
7,276 |
2003-07-01 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director |
2021-10-01 |
29,801 |
|
0 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
CEO, Director |
2015-09-30 |
159,416 |
2012-03-12 |
0 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2023-06-23 |
64,445 |
2020-06-15 |
0 |
Premium* |
|
|
Cyclerion Therapeutics, Inc. |
CYCN |
|
2023-11-30 |
30,000 |
2023-11-30 |
0 |
Premium* |
|
|
Alector, Inc. |
ALEC |
|
2024-03-19 |
41,250 |
2024-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALEC |
Alector, Inc. |
|
– • – |
2024-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
41,250 |
41,250 |
0 |
- |
|
| CYCN |
Cyclerion Therapeutics, I... |
|
– • – |
2023-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
30,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,747 |
64,445 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
6,328 |
56,698 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2021-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,588 |
29,801 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,406 |
26,213 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2021-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,726 |
50,370 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,129 |
19,881 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,125 |
17,752 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2020-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,129 |
14,627 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,929 |
44,644 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2020-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
35,715 |
35,715 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,860 |
12,498 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,835 |
9,638 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2019-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,545 |
7,803 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,810 |
5,258 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,504 |
3,448 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,703 |
1,944 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CEO |
• • – |
2015-09-30 |
4 |
D |
$0.44 |
$19,126 |
D/D |
(43,469) |
159,416 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CEO |
• • – |
2015-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
131,128 |
202,885 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,333 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CEO |
• • – |
2014-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,625 |
73,517 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CEO |
• • – |
2014-03-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,760) |
71,757 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CEO |
• • – |
2013-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,625 |
59,676 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
CEO |
• • – |
2012-09-30 |
4 |
D |
$2.87 |
$54,453 |
D/D |
(18,973) |
54,051 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
